glp-1 substance abuse What to know about how medications might fight addiction GLP-1 Medications Get at the
Description
2019;10:Ed000142
Biguanides, once responsible for more than 35% of prescriptions, have steadily lost share as patients and providers increasingly turn to GLP1s
Understanding your baseline helps providers design appropriate protocols and creates comparison points for measuring progress
Promotions evolve rapidly, so keep a checklist for comparing new deals
I knew people in my community needed to hear from someone who understood both the clinical side and the lived experience
The evaluating clinician can help determine which delivery format may be most appropriate based on individual health factors and preferences
